nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—ABCB1—colon cancer	0.205	1	CbGaD
Zidovudine—ABCC5—Fluorouracil—colon cancer	0.104	0.183	CbGbCtD
Zidovudine—SLC22A7—Fluorouracil—colon cancer	0.0512	0.0901	CbGbCtD
Zidovudine—ABCC4—Fluorouracil—colon cancer	0.05	0.088	CbGbCtD
Zidovudine—SLC22A11—Methotrexate—colon cancer	0.0296	0.0522	CbGbCtD
Zidovudine—CYP2A6—Fluorouracil—colon cancer	0.0291	0.0511	CbGbCtD
Zidovudine—SLC22A7—Methotrexate—colon cancer	0.0282	0.0497	CbGbCtD
Zidovudine—ABCG2—Irinotecan—colon cancer	0.028	0.0493	CbGbCtD
Zidovudine—ABCC4—Methotrexate—colon cancer	0.0276	0.0485	CbGbCtD
Zidovudine—ABCG2—Fluorouracil—colon cancer	0.0269	0.0473	CbGbCtD
Zidovudine—ABCG2—Vincristine—colon cancer	0.0245	0.0431	CbGbCtD
Zidovudine—ALB—Irinotecan—colon cancer	0.0193	0.034	CbGbCtD
Zidovudine—ALB—Fluorouracil—colon cancer	0.0185	0.0326	CbGbCtD
Zidovudine—SLC22A8—Methotrexate—colon cancer	0.0172	0.0303	CbGbCtD
Zidovudine—CYP2C9—Capecitabine—colon cancer	0.0169	0.0297	CbGbCtD
Zidovudine—ABCG2—Methotrexate—colon cancer	0.0148	0.0261	CbGbCtD
Zidovudine—CYP2C8—Fluorouracil—colon cancer	0.0143	0.0252	CbGbCtD
Zidovudine—SLC22A6—Methotrexate—colon cancer	0.012	0.0211	CbGbCtD
Zidovudine—ALB—Methotrexate—colon cancer	0.0102	0.018	CbGbCtD
Zidovudine—ABCB1—Irinotecan—colon cancer	0.0101	0.0178	CbGbCtD
Zidovudine—CYP2C9—Fluorouracil—colon cancer	0.00999	0.0176	CbGbCtD
Zidovudine—ABCB1—Vincristine—colon cancer	0.00883	0.0155	CbGbCtD
Zidovudine—CYP3A4—Irinotecan—colon cancer	0.00605	0.0107	CbGbCtD
Zidovudine—ABCB1—Methotrexate—colon cancer	0.00535	0.00941	CbGbCtD
Zidovudine—CYP3A4—Vincristine—colon cancer	0.00529	0.00932	CbGbCtD
Zidovudine—TERT—embryo—colon cancer	0.00385	0.0665	CbGeAlD
Zidovudine—TERT—epithelium—colon cancer	0.00314	0.0543	CbGeAlD
Zidovudine—SLC28A1—renal system—colon cancer	0.00296	0.0513	CbGeAlD
Zidovudine—Floxuridine—TYMS—colon cancer	0.00253	0.557	CrCbGaD
Zidovudine—SLC28A1—digestive system—colon cancer	0.00243	0.0421	CbGeAlD
Zidovudine—TERT—lymphoid tissue—colon cancer	0.00242	0.0418	CbGeAlD
Zidovudine—TERT—digestive system—colon cancer	0.00239	0.0413	CbGeAlD
Zidovudine—TK1—epithelium—colon cancer	0.00216	0.0374	CbGeAlD
Zidovudine—Trifluridine—TYMS—colon cancer	0.00201	0.443	CrCbGaD
Zidovudine—SLC28A1—liver—colon cancer	0.00181	0.0313	CbGeAlD
Zidovudine—TERT—liver—colon cancer	0.00178	0.0308	CbGeAlD
Zidovudine—TK1—lymphoid tissue—colon cancer	0.00166	0.0288	CbGeAlD
Zidovudine—TK1—digestive system—colon cancer	0.00164	0.0284	CbGeAlD
Zidovudine—TK1—bone marrow—colon cancer	0.00151	0.0262	CbGeAlD
Zidovudine—TK1—vagina—colon cancer	0.00145	0.0251	CbGeAlD
Zidovudine—ALB—gall bladder—colon cancer	0.00133	0.0231	CbGeAlD
Zidovudine—SLC29A2—vagina—colon cancer	0.0012	0.0208	CbGeAlD
Zidovudine—UGT2B7—renal system—colon cancer	0.00112	0.0194	CbGeAlD
Zidovudine—SLC22A11—renal system—colon cancer	0.00109	0.0189	CbGeAlD
Zidovudine—SLC22A7—renal system—colon cancer	0.00106	0.0184	CbGeAlD
Zidovudine—SLC29A2—liver—colon cancer	0.00101	0.0175	CbGeAlD
Zidovudine—SLC22A2—renal system—colon cancer	0.000947	0.0164	CbGeAlD
Zidovudine—TK1—lymph node—colon cancer	0.000938	0.0162	CbGeAlD
Zidovudine—UGT2B7—digestive system—colon cancer	0.000918	0.0159	CbGeAlD
Zidovudine—SLC22A11—digestive system—colon cancer	0.000894	0.0155	CbGeAlD
Zidovudine—SLC22A7—digestive system—colon cancer	0.000873	0.0151	CbGeAlD
Zidovudine—SLC22A2—digestive system—colon cancer	0.000777	0.0134	CbGeAlD
Zidovudine—SLC29A2—lymph node—colon cancer	0.000776	0.0134	CbGeAlD
Zidovudine—UGT2B7—liver—colon cancer	0.000684	0.0118	CbGeAlD
Zidovudine—ABCC5—bone marrow—colon cancer	0.000676	0.0117	CbGeAlD
Zidovudine—SLC22A11—liver—colon cancer	0.000666	0.0115	CbGeAlD
Zidovudine—SLC22A7—liver—colon cancer	0.00065	0.0113	CbGeAlD
Zidovudine—ABCC5—vagina—colon cancer	0.000648	0.0112	CbGeAlD
Zidovudine—ABCC4—renal system—colon cancer	0.00062	0.0107	CbGeAlD
Zidovudine—SLC22A8—renal system—colon cancer	0.000615	0.0106	CbGeAlD
Zidovudine—CYP2A6—vagina—colon cancer	0.000581	0.01	CbGeAlD
Zidovudine—ABCC5—liver—colon cancer	0.000547	0.00946	CbGeAlD
Zidovudine—ABCC4—digestive system—colon cancer	0.000509	0.0088	CbGeAlD
Zidovudine—CYP2A6—liver—colon cancer	0.00049	0.00848	CbGeAlD
Zidovudine—ABCB1—blood vessel—colon cancer	0.000478	0.00827	CbGeAlD
Zidovudine—ABCC4—bone marrow—colon cancer	0.000469	0.00811	CbGeAlD
Zidovudine—CYP2C8—renal system—colon cancer	0.00045	0.00779	CbGeAlD
Zidovudine—CYP2C19—digestive system—colon cancer	0.000423	0.00732	CbGeAlD
Zidovudine—ABCC5—lymph node—colon cancer	0.000419	0.00725	CbGeAlD
Zidovudine—ALB—liver—colon cancer	0.000391	0.00677	CbGeAlD
Zidovudine—ABCC4—liver—colon cancer	0.000379	0.00656	CbGeAlD
Zidovudine—CYP2C19—vagina—colon cancer	0.000374	0.00646	CbGeAlD
Zidovudine—ABCG2—bone marrow—colon cancer	0.000331	0.00573	CbGeAlD
Zidovudine—CYP2C9—digestive system—colon cancer	0.000328	0.00567	CbGeAlD
Zidovudine—CYP2C8—vagina—colon cancer	0.000326	0.00564	CbGeAlD
Zidovudine—ABCG2—vagina—colon cancer	0.000317	0.00549	CbGeAlD
Zidovudine—CYP2C19—liver—colon cancer	0.000315	0.00545	CbGeAlD
Zidovudine—CYP3A4—renal system—colon cancer	0.000305	0.00528	CbGeAlD
Zidovudine—ALB—lymph node—colon cancer	0.0003	0.00519	CbGeAlD
Zidovudine—ABCC4—lymph node—colon cancer	0.00029	0.00503	CbGeAlD
Zidovudine—ABCB1—embryo—colon cancer	0.000285	0.00493	CbGeAlD
Zidovudine—CYP2C8—liver—colon cancer	0.000275	0.00476	CbGeAlD
Zidovudine—ABCG2—liver—colon cancer	0.000267	0.00463	CbGeAlD
Zidovudine—CYP3A4—digestive system—colon cancer	0.00025	0.00433	CbGeAlD
Zidovudine—Anaemia—Vincristine—colon cancer	0.000249	0.00256	CcSEcCtD
Zidovudine—Polyuria—Methotrexate—colon cancer	0.000247	0.00254	CcSEcCtD
Zidovudine—Sweating increased—Capecitabine—colon cancer	0.000245	0.00253	CcSEcCtD
Zidovudine—CYP2C9—liver—colon cancer	0.000244	0.00423	CbGeAlD
Zidovudine—Ill-defined disorder—Irinotecan—colon cancer	0.000243	0.00251	CcSEcCtD
Zidovudine—Anaemia—Irinotecan—colon cancer	0.000242	0.0025	CcSEcCtD
Zidovudine—Vertigo—Vincristine—colon cancer	0.000242	0.00249	CcSEcCtD
Zidovudine—Leukopenia—Vincristine—colon cancer	0.000241	0.00248	CcSEcCtD
Zidovudine—Pancytopenia—Capecitabine—colon cancer	0.000239	0.00246	CcSEcCtD
Zidovudine—Malaise—Irinotecan—colon cancer	0.000236	0.00244	CcSEcCtD
Zidovudine—Vertigo—Irinotecan—colon cancer	0.000236	0.00243	CcSEcCtD
Zidovudine—Neutropenia—Capecitabine—colon cancer	0.000236	0.00243	CcSEcCtD
Zidovudine—Dysuria—Capecitabine—colon cancer	0.000236	0.00243	CcSEcCtD
Zidovudine—Syncope—Irinotecan—colon cancer	0.000235	0.00242	CcSEcCtD
Zidovudine—Leukopenia—Irinotecan—colon cancer	0.000235	0.00242	CcSEcCtD
Zidovudine—Convulsion—Vincristine—colon cancer	0.000233	0.0024	CcSEcCtD
Zidovudine—ABCB1—epithelium—colon cancer	0.000233	0.00403	CbGeAlD
Zidovudine—Anaemia—Fluorouracil—colon cancer	0.000232	0.00239	CcSEcCtD
Zidovudine—Loss of consciousness—Irinotecan—colon cancer	0.00023	0.00237	CcSEcCtD
Zidovudine—Myalgia—Vincristine—colon cancer	0.000229	0.00236	CcSEcCtD
Zidovudine—Cough—Irinotecan—colon cancer	0.000229	0.00236	CcSEcCtD
Zidovudine—Weight decreased—Capecitabine—colon cancer	0.000228	0.00235	CcSEcCtD
Zidovudine—Leukopenia—Fluorouracil—colon cancer	0.000225	0.00232	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000223	0.00229	CcSEcCtD
Zidovudine—Discomfort—Irinotecan—colon cancer	0.000221	0.00227	CcSEcCtD
Zidovudine—Neuropathy peripheral—Capecitabine—colon cancer	0.00022	0.00227	CcSEcCtD
Zidovudine—Anaphylactic shock—Vincristine—colon cancer	0.00022	0.00226	CcSEcCtD
Zidovudine—Oedema—Vincristine—colon cancer	0.00022	0.00226	CcSEcCtD
Zidovudine—Stomatitis—Capecitabine—colon cancer	0.000219	0.00225	CcSEcCtD
Zidovudine—Jaundice—Capecitabine—colon cancer	0.000219	0.00225	CcSEcCtD
Zidovudine—Convulsion—Fluorouracil—colon cancer	0.000218	0.00224	CcSEcCtD
Zidovudine—ABCB1—renal system—colon cancer	0.000216	0.00373	CbGeAlD
Zidovudine—Confusional state—Irinotecan—colon cancer	0.000216	0.00222	CcSEcCtD
Zidovudine—Nervous system disorder—Vincristine—colon cancer	0.000215	0.00222	CcSEcCtD
Zidovudine—Thrombocytopenia—Vincristine—colon cancer	0.000215	0.00222	CcSEcCtD
Zidovudine—Haematuria—Capecitabine—colon cancer	0.000214	0.00221	CcSEcCtD
Zidovudine—Oedema—Irinotecan—colon cancer	0.000214	0.0022	CcSEcCtD
Zidovudine—Anaphylactic shock—Irinotecan—colon cancer	0.000214	0.0022	CcSEcCtD
Zidovudine—Myalgia—Fluorouracil—colon cancer	0.000214	0.0022	CcSEcCtD
Zidovudine—Chest pain—Fluorouracil—colon cancer	0.000214	0.0022	CcSEcCtD
Zidovudine—Hyperhidrosis—Vincristine—colon cancer	0.000212	0.00219	CcSEcCtD
Zidovudine—Hepatobiliary disease—Capecitabine—colon cancer	0.000212	0.00219	CcSEcCtD
Zidovudine—Epistaxis—Capecitabine—colon cancer	0.000212	0.00218	CcSEcCtD
Zidovudine—Discomfort—Fluorouracil—colon cancer	0.000211	0.00218	CcSEcCtD
Zidovudine—Shock—Irinotecan—colon cancer	0.000211	0.00217	CcSEcCtD
Zidovudine—Nervous system disorder—Irinotecan—colon cancer	0.00021	0.00216	CcSEcCtD
Zidovudine—Agranulocytosis—Capecitabine—colon cancer	0.00021	0.00216	CcSEcCtD
Zidovudine—Thrombocytopenia—Irinotecan—colon cancer	0.00021	0.00216	CcSEcCtD
Zidovudine—Anorexia—Vincristine—colon cancer	0.000209	0.00216	CcSEcCtD
Zidovudine—Irritability—Methotrexate—colon cancer	0.000207	0.00213	CcSEcCtD
Zidovudine—Hyperhidrosis—Irinotecan—colon cancer	0.000207	0.00213	CcSEcCtD
Zidovudine—Confusional state—Fluorouracil—colon cancer	0.000207	0.00213	CcSEcCtD
Zidovudine—Mood swings—Methotrexate—colon cancer	0.000206	0.00212	CcSEcCtD
Zidovudine—ABCG2—lymph node—colon cancer	0.000205	0.00355	CbGeAlD
Zidovudine—Anaphylactic shock—Fluorouracil—colon cancer	0.000205	0.00211	CcSEcCtD
Zidovudine—Oedema—Fluorouracil—colon cancer	0.000205	0.00211	CcSEcCtD
Zidovudine—Anorexia—Irinotecan—colon cancer	0.000204	0.0021	CcSEcCtD
Zidovudine—Rhinitis—Capecitabine—colon cancer	0.000202	0.00208	CcSEcCtD
Zidovudine—Hepatitis—Capecitabine—colon cancer	0.000202	0.00208	CcSEcCtD
Zidovudine—Nervous system disorder—Fluorouracil—colon cancer	0.000201	0.00207	CcSEcCtD
Zidovudine—Thrombocytopenia—Fluorouracil—colon cancer	0.000201	0.00207	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Vincristine—colon cancer	0.0002	0.00206	CcSEcCtD
Zidovudine—Pharyngitis—Capecitabine—colon cancer	0.0002	0.00206	CcSEcCtD
Zidovudine—Urinary tract disorder—Capecitabine—colon cancer	0.000199	0.00205	CcSEcCtD
Zidovudine—Insomnia—Vincristine—colon cancer	0.000199	0.00205	CcSEcCtD
Zidovudine—Connective tissue disorder—Capecitabine—colon cancer	0.000198	0.00204	CcSEcCtD
Zidovudine—Urethral disorder—Capecitabine—colon cancer	0.000198	0.00204	CcSEcCtD
Zidovudine—Paraesthesia—Vincristine—colon cancer	0.000197	0.00203	CcSEcCtD
Zidovudine—Breast disorder—Methotrexate—colon cancer	0.000196	0.00202	CcSEcCtD
Zidovudine—Anorexia—Fluorouracil—colon cancer	0.000195	0.00201	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000195	0.00201	CcSEcCtD
Zidovudine—Insomnia—Irinotecan—colon cancer	0.000194	0.00199	CcSEcCtD
Zidovudine—Paraesthesia—Irinotecan—colon cancer	0.000192	0.00198	CcSEcCtD
Zidovudine—Decreased appetite—Vincristine—colon cancer	0.000191	0.00197	CcSEcCtD
Zidovudine—Dyspnoea—Irinotecan—colon cancer	0.000191	0.00197	CcSEcCtD
Zidovudine—Erythema multiforme—Capecitabine—colon cancer	0.000191	0.00196	CcSEcCtD
Zidovudine—Somnolence—Irinotecan—colon cancer	0.00019	0.00196	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Vincristine—colon cancer	0.00019	0.00195	CcSEcCtD
Zidovudine—Fatigue—Vincristine—colon cancer	0.000189	0.00195	CcSEcCtD
Zidovudine—Dyspepsia—Irinotecan—colon cancer	0.000188	0.00194	CcSEcCtD
Zidovudine—Constipation—Vincristine—colon cancer	0.000188	0.00194	CcSEcCtD
Zidovudine—Pain—Vincristine—colon cancer	0.000188	0.00194	CcSEcCtD
Zidovudine—Cardiac disorder—Capecitabine—colon cancer	0.000187	0.00193	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000187	0.00192	CcSEcCtD
Zidovudine—CYP3A4—liver—colon cancer	0.000186	0.00322	CbGeAlD
Zidovudine—Decreased appetite—Irinotecan—colon cancer	0.000186	0.00192	CcSEcCtD
Zidovudine—Insomnia—Fluorouracil—colon cancer	0.000185	0.00191	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000185	0.0019	CcSEcCtD
Zidovudine—Fatigue—Irinotecan—colon cancer	0.000185	0.0019	CcSEcCtD
Zidovudine—Paraesthesia—Fluorouracil—colon cancer	0.000184	0.0019	CcSEcCtD
Zidovudine—Pancreatitis—Methotrexate—colon cancer	0.000184	0.00189	CcSEcCtD
Zidovudine—Pain—Irinotecan—colon cancer	0.000183	0.00188	CcSEcCtD
Zidovudine—Constipation—Irinotecan—colon cancer	0.000183	0.00188	CcSEcCtD
Zidovudine—Dyspnoea—Fluorouracil—colon cancer	0.000183	0.00188	CcSEcCtD
Zidovudine—Somnolence—Fluorouracil—colon cancer	0.000182	0.00188	CcSEcCtD
Zidovudine—Mediastinal disorder—Capecitabine—colon cancer	0.000182	0.00187	CcSEcCtD
Zidovudine—Chills—Capecitabine—colon cancer	0.000181	0.00186	CcSEcCtD
Zidovudine—Dyspepsia—Fluorouracil—colon cancer	0.00018	0.00186	CcSEcCtD
Zidovudine—Gastrointestinal pain—Vincristine—colon cancer	0.00018	0.00185	CcSEcCtD
Zidovudine—ABCB1—lymphoid tissue—colon cancer	0.000179	0.0031	CbGeAlD
Zidovudine—Decreased appetite—Fluorouracil—colon cancer	0.000178	0.00184	CcSEcCtD
Zidovudine—Pancytopenia—Methotrexate—colon cancer	0.000178	0.00183	CcSEcCtD
Zidovudine—ABCB1—digestive system—colon cancer	0.000177	0.00306	CbGeAlD
Zidovudine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000177	0.00182	CcSEcCtD
Zidovudine—Mental disorder—Capecitabine—colon cancer	0.000177	0.00182	CcSEcCtD
Zidovudine—Feeling abnormal—Irinotecan—colon cancer	0.000176	0.00182	CcSEcCtD
Zidovudine—Malnutrition—Capecitabine—colon cancer	0.000175	0.00181	CcSEcCtD
Zidovudine—Erythema—Capecitabine—colon cancer	0.000175	0.00181	CcSEcCtD
Zidovudine—Dysuria—Methotrexate—colon cancer	0.000175	0.00181	CcSEcCtD
Zidovudine—Neutropenia—Methotrexate—colon cancer	0.000175	0.00181	CcSEcCtD
Zidovudine—Pain—Fluorouracil—colon cancer	0.000175	0.00181	CcSEcCtD
Zidovudine—Gastrointestinal pain—Irinotecan—colon cancer	0.000175	0.0018	CcSEcCtD
Zidovudine—Abdominal pain—Vincristine—colon cancer	0.000174	0.00179	CcSEcCtD
Zidovudine—Body temperature increased—Vincristine—colon cancer	0.000174	0.00179	CcSEcCtD
Zidovudine—Flatulence—Capecitabine—colon cancer	0.000173	0.00178	CcSEcCtD
Zidovudine—Dysgeusia—Capecitabine—colon cancer	0.000172	0.00177	CcSEcCtD
Zidovudine—Back pain—Capecitabine—colon cancer	0.00017	0.00175	CcSEcCtD
Zidovudine—Body temperature increased—Irinotecan—colon cancer	0.000169	0.00174	CcSEcCtD
Zidovudine—Abdominal pain—Irinotecan—colon cancer	0.000169	0.00174	CcSEcCtD
Zidovudine—Feeling abnormal—Fluorouracil—colon cancer	0.000169	0.00174	CcSEcCtD
Zidovudine—Muscle spasms—Capecitabine—colon cancer	0.000169	0.00174	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000166	0.00171	CcSEcCtD
Zidovudine—Tremor—Capecitabine—colon cancer	0.000164	0.00169	CcSEcCtD
Zidovudine—ABCB1—bone marrow—colon cancer	0.000163	0.00282	CbGeAlD
Zidovudine—Stomatitis—Methotrexate—colon cancer	0.000163	0.00168	CcSEcCtD
Zidovudine—Ill-defined disorder—Capecitabine—colon cancer	0.000163	0.00168	CcSEcCtD
Zidovudine—Urticaria—Fluorouracil—colon cancer	0.000163	0.00168	CcSEcCtD
Zidovudine—Anaemia—Capecitabine—colon cancer	0.000162	0.00167	CcSEcCtD
Zidovudine—Body temperature increased—Fluorouracil—colon cancer	0.000162	0.00167	CcSEcCtD
Zidovudine—Sweating—Methotrexate—colon cancer	0.00016	0.00165	CcSEcCtD
Zidovudine—Haematuria—Methotrexate—colon cancer	0.000159	0.00164	CcSEcCtD
Zidovudine—Malaise—Capecitabine—colon cancer	0.000158	0.00163	CcSEcCtD
Zidovudine—Hepatobiliary disease—Methotrexate—colon cancer	0.000158	0.00163	CcSEcCtD
Zidovudine—Epistaxis—Methotrexate—colon cancer	0.000158	0.00162	CcSEcCtD
Zidovudine—Vertigo—Capecitabine—colon cancer	0.000158	0.00162	CcSEcCtD
Zidovudine—Asthenia—Vincristine—colon cancer	0.000158	0.00162	CcSEcCtD
Zidovudine—Syncope—Capecitabine—colon cancer	0.000157	0.00162	CcSEcCtD
Zidovudine—Leukopenia—Capecitabine—colon cancer	0.000157	0.00162	CcSEcCtD
Zidovudine—ABCB1—vagina—colon cancer	0.000156	0.0027	CbGeAlD
Zidovudine—Agranulocytosis—Methotrexate—colon cancer	0.000156	0.00161	CcSEcCtD
Zidovudine—Loss of consciousness—Capecitabine—colon cancer	0.000154	0.00159	CcSEcCtD
Zidovudine—Asthenia—Irinotecan—colon cancer	0.000154	0.00158	CcSEcCtD
Zidovudine—Cough—Capecitabine—colon cancer	0.000153	0.00158	CcSEcCtD
Zidovudine—Diarrhoea—Vincristine—colon cancer	0.00015	0.00155	CcSEcCtD
Zidovudine—Hepatitis—Methotrexate—colon cancer	0.00015	0.00155	CcSEcCtD
Zidovudine—Chest pain—Capecitabine—colon cancer	0.000149	0.00154	CcSEcCtD
Zidovudine—Myalgia—Capecitabine—colon cancer	0.000149	0.00154	CcSEcCtD
Zidovudine—Arthralgia—Capecitabine—colon cancer	0.000149	0.00154	CcSEcCtD
Zidovudine—Pharyngitis—Methotrexate—colon cancer	0.000149	0.00153	CcSEcCtD
Zidovudine—Anxiety—Capecitabine—colon cancer	0.000149	0.00153	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000148	0.00153	CcSEcCtD
Zidovudine—Urinary tract disorder—Methotrexate—colon cancer	0.000148	0.00153	CcSEcCtD
Zidovudine—Discomfort—Capecitabine—colon cancer	0.000148	0.00152	CcSEcCtD
Zidovudine—Urethral disorder—Methotrexate—colon cancer	0.000147	0.00152	CcSEcCtD
Zidovudine—Diarrhoea—Irinotecan—colon cancer	0.000146	0.00151	CcSEcCtD
Zidovudine—Dizziness—Vincristine—colon cancer	0.000145	0.0015	CcSEcCtD
Zidovudine—Pruritus—Fluorouracil—colon cancer	0.000145	0.00149	CcSEcCtD
Zidovudine—Confusional state—Capecitabine—colon cancer	0.000144	0.00149	CcSEcCtD
Zidovudine—Oedema—Capecitabine—colon cancer	0.000143	0.00148	CcSEcCtD
Zidovudine—Erythema multiforme—Methotrexate—colon cancer	0.000142	0.00146	CcSEcCtD
Zidovudine—Dizziness—Irinotecan—colon cancer	0.000142	0.00146	CcSEcCtD
Zidovudine—Shock—Capecitabine—colon cancer	0.000141	0.00145	CcSEcCtD
Zidovudine—Nervous system disorder—Capecitabine—colon cancer	0.00014	0.00145	CcSEcCtD
Zidovudine—Diarrhoea—Fluorouracil—colon cancer	0.00014	0.00144	CcSEcCtD
Zidovudine—Thrombocytopenia—Capecitabine—colon cancer	0.00014	0.00144	CcSEcCtD
Zidovudine—Vomiting—Vincristine—colon cancer	0.00014	0.00144	CcSEcCtD
Zidovudine—Cardiac disorder—Methotrexate—colon cancer	0.000139	0.00143	CcSEcCtD
Zidovudine—Skin disorder—Capecitabine—colon cancer	0.000139	0.00143	CcSEcCtD
Zidovudine—Rash—Vincristine—colon cancer	0.000139	0.00143	CcSEcCtD
Zidovudine—Hyperhidrosis—Capecitabine—colon cancer	0.000138	0.00143	CcSEcCtD
Zidovudine—Dermatitis—Vincristine—colon cancer	0.000138	0.00143	CcSEcCtD
Zidovudine—Headache—Vincristine—colon cancer	0.000138	0.00142	CcSEcCtD
Zidovudine—Anorexia—Capecitabine—colon cancer	0.000137	0.00141	CcSEcCtD
Zidovudine—Vomiting—Irinotecan—colon cancer	0.000136	0.0014	CcSEcCtD
Zidovudine—Dizziness—Fluorouracil—colon cancer	0.000136	0.0014	CcSEcCtD
Zidovudine—Mediastinal disorder—Methotrexate—colon cancer	0.000135	0.00139	CcSEcCtD
Zidovudine—Rash—Irinotecan—colon cancer	0.000135	0.00139	CcSEcCtD
Zidovudine—Dermatitis—Irinotecan—colon cancer	0.000135	0.00139	CcSEcCtD
Zidovudine—Chills—Methotrexate—colon cancer	0.000135	0.00139	CcSEcCtD
Zidovudine—Headache—Irinotecan—colon cancer	0.000134	0.00138	CcSEcCtD
Zidovudine—ABCB1—liver—colon cancer	0.000132	0.00228	CbGeAlD
Zidovudine—Mental disorder—Methotrexate—colon cancer	0.000131	0.00135	CcSEcCtD
Zidovudine—Erythema—Methotrexate—colon cancer	0.000131	0.00135	CcSEcCtD
Zidovudine—Malnutrition—Methotrexate—colon cancer	0.000131	0.00135	CcSEcCtD
Zidovudine—Nausea—Vincristine—colon cancer	0.000131	0.00134	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00013	0.00134	CcSEcCtD
Zidovudine—Vomiting—Fluorouracil—colon cancer	0.00013	0.00134	CcSEcCtD
Zidovudine—Insomnia—Capecitabine—colon cancer	0.00013	0.00133	CcSEcCtD
Zidovudine—Rash—Fluorouracil—colon cancer	0.000129	0.00133	CcSEcCtD
Zidovudine—Dermatitis—Fluorouracil—colon cancer	0.000129	0.00133	CcSEcCtD
Zidovudine—Paraesthesia—Capecitabine—colon cancer	0.000129	0.00132	CcSEcCtD
Zidovudine—Headache—Fluorouracil—colon cancer	0.000128	0.00132	CcSEcCtD
Zidovudine—Dysgeusia—Methotrexate—colon cancer	0.000128	0.00132	CcSEcCtD
Zidovudine—Dyspnoea—Capecitabine—colon cancer	0.000128	0.00132	CcSEcCtD
Zidovudine—Nausea—Irinotecan—colon cancer	0.000127	0.00131	CcSEcCtD
Zidovudine—Back pain—Methotrexate—colon cancer	0.000126	0.0013	CcSEcCtD
Zidovudine—Dyspepsia—Capecitabine—colon cancer	0.000126	0.0013	CcSEcCtD
Zidovudine—Decreased appetite—Capecitabine—colon cancer	0.000125	0.00128	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000124	0.00127	CcSEcCtD
Zidovudine—Fatigue—Capecitabine—colon cancer	0.000123	0.00127	CcSEcCtD
Zidovudine—Pain—Capecitabine—colon cancer	0.000122	0.00126	CcSEcCtD
Zidovudine—Constipation—Capecitabine—colon cancer	0.000122	0.00126	CcSEcCtD
Zidovudine—Nausea—Fluorouracil—colon cancer	0.000122	0.00125	CcSEcCtD
Zidovudine—Ill-defined disorder—Methotrexate—colon cancer	0.000121	0.00125	CcSEcCtD
Zidovudine—Anaemia—Methotrexate—colon cancer	0.000121	0.00124	CcSEcCtD
Zidovudine—Feeling abnormal—Capecitabine—colon cancer	0.000118	0.00122	CcSEcCtD
Zidovudine—Malaise—Methotrexate—colon cancer	0.000118	0.00121	CcSEcCtD
Zidovudine—Vertigo—Methotrexate—colon cancer	0.000117	0.00121	CcSEcCtD
Zidovudine—Gastrointestinal pain—Capecitabine—colon cancer	0.000117	0.00121	CcSEcCtD
Zidovudine—Leukopenia—Methotrexate—colon cancer	0.000117	0.0012	CcSEcCtD
Zidovudine—Cough—Methotrexate—colon cancer	0.000114	0.00117	CcSEcCtD
Zidovudine—Urticaria—Capecitabine—colon cancer	0.000114	0.00117	CcSEcCtD
Zidovudine—Abdominal pain—Capecitabine—colon cancer	0.000113	0.00117	CcSEcCtD
Zidovudine—Body temperature increased—Capecitabine—colon cancer	0.000113	0.00117	CcSEcCtD
Zidovudine—Convulsion—Methotrexate—colon cancer	0.000113	0.00117	CcSEcCtD
Zidovudine—Myalgia—Methotrexate—colon cancer	0.000111	0.00115	CcSEcCtD
Zidovudine—Arthralgia—Methotrexate—colon cancer	0.000111	0.00115	CcSEcCtD
Zidovudine—Chest pain—Methotrexate—colon cancer	0.000111	0.00115	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00011	0.00114	CcSEcCtD
Zidovudine—Discomfort—Methotrexate—colon cancer	0.00011	0.00113	CcSEcCtD
Zidovudine—Confusional state—Methotrexate—colon cancer	0.000108	0.00111	CcSEcCtD
Zidovudine—Anaphylactic shock—Methotrexate—colon cancer	0.000107	0.0011	CcSEcCtD
Zidovudine—Nervous system disorder—Methotrexate—colon cancer	0.000105	0.00108	CcSEcCtD
Zidovudine—Thrombocytopenia—Methotrexate—colon cancer	0.000104	0.00108	CcSEcCtD
Zidovudine—Skin disorder—Methotrexate—colon cancer	0.000104	0.00107	CcSEcCtD
Zidovudine—Hyperhidrosis—Methotrexate—colon cancer	0.000103	0.00106	CcSEcCtD
Zidovudine—Asthenia—Capecitabine—colon cancer	0.000103	0.00106	CcSEcCtD
Zidovudine—Anorexia—Methotrexate—colon cancer	0.000102	0.00105	CcSEcCtD
Zidovudine—Pruritus—Capecitabine—colon cancer	0.000101	0.00104	CcSEcCtD
Zidovudine—ABCB1—lymph node—colon cancer	0.000101	0.00175	CbGeAlD
Zidovudine—Diarrhoea—Capecitabine—colon cancer	9.8e-05	0.00101	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Methotrexate—colon cancer	9.71e-05	0.001	CcSEcCtD
Zidovudine—Insomnia—Methotrexate—colon cancer	9.64e-05	0.000993	CcSEcCtD
Zidovudine—Paraesthesia—Methotrexate—colon cancer	9.57e-05	0.000986	CcSEcCtD
Zidovudine—Dyspnoea—Methotrexate—colon cancer	9.51e-05	0.000979	CcSEcCtD
Zidovudine—Somnolence—Methotrexate—colon cancer	9.48e-05	0.000976	CcSEcCtD
Zidovudine—Dizziness—Capecitabine—colon cancer	9.47e-05	0.000976	CcSEcCtD
Zidovudine—Dyspepsia—Methotrexate—colon cancer	9.39e-05	0.000967	CcSEcCtD
Zidovudine—Decreased appetite—Methotrexate—colon cancer	9.27e-05	0.000955	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Methotrexate—colon cancer	9.21e-05	0.000948	CcSEcCtD
Zidovudine—Fatigue—Methotrexate—colon cancer	9.19e-05	0.000947	CcSEcCtD
Zidovudine—Pain—Methotrexate—colon cancer	9.12e-05	0.000939	CcSEcCtD
Zidovudine—Vomiting—Capecitabine—colon cancer	9.11e-05	0.000938	CcSEcCtD
Zidovudine—Rash—Capecitabine—colon cancer	9.03e-05	0.00093	CcSEcCtD
Zidovudine—Dermatitis—Capecitabine—colon cancer	9.02e-05	0.000929	CcSEcCtD
Zidovudine—Headache—Capecitabine—colon cancer	8.97e-05	0.000924	CcSEcCtD
Zidovudine—Feeling abnormal—Methotrexate—colon cancer	8.79e-05	0.000905	CcSEcCtD
Zidovudine—Gastrointestinal pain—Methotrexate—colon cancer	8.72e-05	0.000898	CcSEcCtD
Zidovudine—Nausea—Capecitabine—colon cancer	8.51e-05	0.000876	CcSEcCtD
Zidovudine—Urticaria—Methotrexate—colon cancer	8.47e-05	0.000872	CcSEcCtD
Zidovudine—Abdominal pain—Methotrexate—colon cancer	8.43e-05	0.000868	CcSEcCtD
Zidovudine—Body temperature increased—Methotrexate—colon cancer	8.43e-05	0.000868	CcSEcCtD
Zidovudine—Asthenia—Methotrexate—colon cancer	7.65e-05	0.000788	CcSEcCtD
Zidovudine—Pruritus—Methotrexate—colon cancer	7.54e-05	0.000777	CcSEcCtD
Zidovudine—Diarrhoea—Methotrexate—colon cancer	7.3e-05	0.000751	CcSEcCtD
Zidovudine—Dizziness—Methotrexate—colon cancer	7.05e-05	0.000726	CcSEcCtD
Zidovudine—Vomiting—Methotrexate—colon cancer	6.78e-05	0.000698	CcSEcCtD
Zidovudine—Rash—Methotrexate—colon cancer	6.72e-05	0.000692	CcSEcCtD
Zidovudine—Dermatitis—Methotrexate—colon cancer	6.72e-05	0.000692	CcSEcCtD
Zidovudine—Headache—Methotrexate—colon cancer	6.68e-05	0.000688	CcSEcCtD
Zidovudine—Nausea—Methotrexate—colon cancer	6.33e-05	0.000652	CcSEcCtD
Zidovudine—ALB—Metabolism—CA7—colon cancer	4.97e-05	0.000732	CbGpPWpGaD
Zidovudine—TERT—Disease—APC—colon cancer	4.96e-05	0.000731	CbGpPWpGaD
Zidovudine—UGT2B7—NRF2 pathway—TGFB1—colon cancer	4.94e-05	0.000727	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ODC1—colon cancer	4.88e-05	0.000719	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CHST5—colon cancer	4.88e-05	0.000719	CbGpPWpGaD
Zidovudine—ABCC4—Ectoderm Differentiation—MYC—colon cancer	4.87e-05	0.000716	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ODC1—colon cancer	4.83e-05	0.000711	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CHST5—colon cancer	4.83e-05	0.000711	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	4.8e-05	0.000707	CbGpPWpGaD
Zidovudine—TERT—Disease—BRAF—colon cancer	4.66e-05	0.000687	CbGpPWpGaD
Zidovudine—SLC22A7—Transmembrane transport of small molecules—ABCB1—colon cancer	4.66e-05	0.000686	CbGpPWpGaD
Zidovudine—ABCC4—NRF2 pathway—TGFB1—colon cancer	4.64e-05	0.000683	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—BRAF—colon cancer	4.48e-05	0.00066	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	4.47e-05	0.000657	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CA7—colon cancer	4.46e-05	0.000657	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PPARG—colon cancer	4.44e-05	0.000653	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ODC1—colon cancer	4.44e-05	0.000653	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CHST5—colon cancer	4.44e-05	0.000653	CbGpPWpGaD
Zidovudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	4.42e-05	0.00065	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—TP53—colon cancer	4.37e-05	0.000644	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CA7—colon cancer	4.36e-05	0.000641	CbGpPWpGaD
Zidovudine—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	4.35e-05	0.000641	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CA7—colon cancer	4.07e-05	0.000599	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	3.99e-05	0.000588	CbGpPWpGaD
Zidovudine—SLC22A8—Transmembrane transport of small molecules—ABCB1—colon cancer	3.92e-05	0.000577	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—CASP3—colon cancer	3.86e-05	0.000568	CbGpPWpGaD
Zidovudine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	3.81e-05	0.000561	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—FGFR3—colon cancer	3.79e-05	0.000557	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	3.78e-05	0.000557	CbGpPWpGaD
Zidovudine—TERT—Disease—PTGS2—colon cancer	3.77e-05	0.000555	CbGpPWpGaD
Zidovudine—ABCC4—Transmembrane transport of small molecules—ABCB1—colon cancer	3.76e-05	0.000553	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—SRC—colon cancer	3.73e-05	0.000549	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—VEGFA—colon cancer	3.7e-05	0.000545	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	3.68e-05	0.000542	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—colon cancer	3.63e-05	0.000534	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.55e-05	0.000522	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	3.53e-05	0.000519	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PTGS2—colon cancer	3.49e-05	0.000514	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—APC—colon cancer	3.48e-05	0.000512	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—BRAF—colon cancer	3.44e-05	0.000506	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—TGFB1—colon cancer	3.4e-05	0.0005	CbGpPWpGaD
Zidovudine—TERT—Disease—CTNNB1—colon cancer	3.37e-05	0.000496	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—colon cancer	3.33e-05	0.00049	CbGpPWpGaD
Zidovudine—TERT—Disease—CDKN1A—colon cancer	3.29e-05	0.000485	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—VEGFA—colon cancer	3.28e-05	0.000482	CbGpPWpGaD
Zidovudine—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	3.27e-05	0.000481	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—BRAF—colon cancer	3.27e-05	0.000481	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TP53—colon cancer	3.26e-05	0.00048	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	3.24e-05	0.000477	CbGpPWpGaD
Zidovudine—TERT—Disease—EP300—colon cancer	3.13e-05	0.000461	CbGpPWpGaD
Zidovudine—CYP2A6—NRF2 pathway—TGFB1—colon cancer	3.09e-05	0.000455	CbGpPWpGaD
Zidovudine—TERT—Disease—SRC—colon cancer	3.05e-05	0.000449	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ODC1—colon cancer	3.03e-05	0.000446	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CHST5—colon cancer	3.03e-05	0.000446	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ODC1—colon cancer	3.01e-05	0.000444	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CHST5—colon cancer	3.01e-05	0.000444	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—TGFB1—colon cancer	3.01e-05	0.000443	CbGpPWpGaD
Zidovudine—TERT—Disease—NRAS—colon cancer	2.93e-05	0.000432	CbGpPWpGaD
Zidovudine—TK1—Metabolism—EP300—colon cancer	2.9e-05	0.000427	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	2.83e-05	0.000417	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.75e-05	0.000406	CbGpPWpGaD
Zidovudine—TERT—Disease—MYC—colon cancer	2.73e-05	0.000402	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.73e-05	0.000401	CbGpPWpGaD
Zidovudine—TERT—Disease—TGFB1—colon cancer	2.72e-05	0.000401	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ODC1—colon cancer	2.7e-05	0.000398	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CHST5—colon cancer	2.7e-05	0.000398	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.7e-05	0.000398	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CA7—colon cancer	2.68e-05	0.000395	CbGpPWpGaD
Zidovudine—TERT—Disease—EGFR—colon cancer	2.67e-05	0.000393	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ODC1—colon cancer	2.64e-05	0.000389	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CHST5—colon cancer	2.64e-05	0.000389	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—ABCB1—colon cancer	2.54e-05	0.000374	CbGpPWpGaD
Zidovudine—TERT—Disease—KRAS—colon cancer	2.52e-05	0.000371	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—TYMS—colon cancer	2.49e-05	0.000367	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ODC1—colon cancer	2.47e-05	0.000363	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CHST5—colon cancer	2.47e-05	0.000363	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CASP3—colon cancer	2.45e-05	0.000361	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.41e-05	0.000355	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CCND1—colon cancer	2.38e-05	0.000351	CbGpPWpGaD
Zidovudine—ABCC5—Disease—FGFR3—colon cancer	2.38e-05	0.00035	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CTNNB1—colon cancer	2.36e-05	0.000348	CbGpPWpGaD
Zidovudine—TERT—Disease—PIK3CA—colon cancer	2.32e-05	0.000341	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—colon cancer	2.32e-05	0.000341	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CDKN1A—colon cancer	2.31e-05	0.00034	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—EP300—colon cancer	2.19e-05	0.000323	CbGpPWpGaD
Zidovudine—ABCC5—Disease—APC—colon cancer	2.18e-05	0.000322	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PIK3CA—colon cancer	2.15e-05	0.000316	CbGpPWpGaD
Zidovudine—TERT—Disease—HRAS—colon cancer	2.14e-05	0.000316	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SRC—colon cancer	2.13e-05	0.000314	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—VEGFA—colon cancer	2.08e-05	0.000306	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—HRAS—colon cancer	2.06e-05	0.000303	CbGpPWpGaD
Zidovudine—ABCC5—Disease—BRAF—colon cancer	2.05e-05	0.000302	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—NRAS—colon cancer	2.05e-05	0.000302	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	2.05e-05	0.000302	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—EP300—colon cancer	1.98e-05	0.000291	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—SRC—colon cancer	1.92e-05	0.000283	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MYC—colon cancer	1.91e-05	0.000282	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TGFB1—colon cancer	1.91e-05	0.000281	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.91e-05	0.000281	CbGpPWpGaD
Zidovudine—TERT—Disease—AKT1—colon cancer	1.89e-05	0.000279	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—ABCB1—colon cancer	1.87e-05	0.000275	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—VEGFA—colon cancer	1.87e-05	0.000275	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—EGFR—colon cancer	1.87e-05	0.000275	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.85e-05	0.000273	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—NRAS—colon cancer	1.85e-05	0.000272	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—TYMS—colon cancer	1.84e-05	0.000271	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.84e-05	0.00027	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.79e-05	0.000264	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—KRAS—colon cancer	1.77e-05	0.00026	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PPARG—colon cancer	1.77e-05	0.00026	CbGpPWpGaD
Zidovudine—TK1—Metabolism—AKT1—colon cancer	1.75e-05	0.000258	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TGFB1—colon cancer	1.72e-05	0.000253	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.71e-05	0.000251	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	1.7e-05	0.00025	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	1.69e-05	0.000248	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.66e-05	0.000244	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTGS2—colon cancer	1.66e-05	0.000244	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.64e-05	0.000242	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ODC1—colon cancer	1.63e-05	0.000239	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CHST5—colon cancer	1.63e-05	0.000239	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PIK3CA—colon cancer	1.62e-05	0.000239	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.62e-05	0.000238	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—KRAS—colon cancer	1.59e-05	0.000234	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—HRAS—colon cancer	1.58e-05	0.000233	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—colon cancer	1.57e-05	0.000231	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.51e-05	0.000222	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HRAS—colon cancer	1.5e-05	0.000221	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.49e-05	0.000219	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CTNNB1—colon cancer	1.48e-05	0.000218	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.48e-05	0.000218	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—PIK3CA—colon cancer	1.46e-05	0.000215	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.46e-05	0.000214	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CDKN1A—colon cancer	1.45e-05	0.000213	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—colon cancer	1.41e-05	0.000208	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTGS2—colon cancer	1.39e-05	0.000205	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EP300—colon cancer	1.38e-05	0.000203	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.37e-05	0.000202	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—HRAS—colon cancer	1.35e-05	0.000199	CbGpPWpGaD
Zidovudine—ABCC5—Disease—SRC—colon cancer	1.34e-05	0.000197	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AKT1—colon cancer	1.33e-05	0.000195	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PPARG—colon cancer	1.3e-05	0.000192	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NRAS—colon cancer	1.29e-05	0.00019	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ABCB1—colon cancer	1.29e-05	0.00019	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	1.28e-05	0.000189	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ABCB1—colon cancer	1.28e-05	0.000188	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—TYMS—colon cancer	1.27e-05	0.000187	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.26e-05	0.000186	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—TYMS—colon cancer	1.25e-05	0.000185	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.25e-05	0.000184	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.24e-05	0.000183	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.22e-05	0.00018	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MYC—colon cancer	1.2e-05	0.000177	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TGFB1—colon cancer	1.2e-05	0.000177	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—AKT1—colon cancer	1.19e-05	0.000176	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EGFR—colon cancer	1.18e-05	0.000173	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ABCB1—colon cancer	1.17e-05	0.000173	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—EP300—colon cancer	1.16e-05	0.00017	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—TYMS—colon cancer	1.15e-05	0.000169	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.12e-05	0.000164	CbGpPWpGaD
Zidovudine—ABCC5—Disease—KRAS—colon cancer	1.11e-05	0.000164	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	1.05e-05	0.000154	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.03e-05	0.000152	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTGS2—colon cancer	1.02e-05	0.000151	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PIK3CA—colon cancer	1.02e-05	0.00015	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.02e-05	0.00015	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.84e-06	0.000145	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.78e-06	0.000144	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HRAS—colon cancer	9.44e-06	0.000139	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PPARG—colon cancer	8.98e-06	0.000132	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—EP300—colon cancer	8.94e-06	0.000132	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PPARG—colon cancer	8.88e-06	0.000131	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.78e-06	0.000129	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SRC—colon cancer	8.69e-06	0.000128	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CA—colon cancer	8.55e-06	0.000126	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—EP300—colon cancer	8.52e-06	0.000125	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VEGFA—colon cancer	8.46e-06	0.000125	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NRAS—colon cancer	8.36e-06	0.000123	CbGpPWpGaD
Zidovudine—ABCC5—Disease—AKT1—colon cancer	8.34e-06	0.000123	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.18e-06	0.00012	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PPARG—colon cancer	8.15e-06	0.00012	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.14e-06	0.00012	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.01e-06	0.000118	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ABCB1—colon cancer	8.01e-06	0.000118	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ABCB1—colon cancer	7.96e-06	0.000117	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TYMS—colon cancer	7.86e-06	0.000116	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TYMS—colon cancer	7.82e-06	0.000115	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TGFB1—colon cancer	7.77e-06	0.000114	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.3e-06	0.000108	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—KRAS—colon cancer	7.2e-06	0.000106	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ABCB1—colon cancer	7.15e-06	0.000105	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTGS2—colon cancer	7.06e-06	0.000104	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TYMS—colon cancer	7.02e-06	0.000103	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTGS2—colon cancer	6.99e-06	0.000103	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—AKT1—colon cancer	6.98e-06	0.000103	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TYMS—colon cancer	6.85e-06	0.000101	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.66e-06	9.81e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CA—colon cancer	6.61e-06	9.73e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ABCB1—colon cancer	6.52e-06	9.59e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS2—colon cancer	6.41e-06	9.44e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TYMS—colon cancer	6.4e-06	9.42e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—colon cancer	6.4e-06	9.42e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CA—colon cancer	6.3e-06	9.28e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HRAS—colon cancer	6.12e-06	9.01e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.05e-06	8.91e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.02e-06	8.86e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—EP300—colon cancer	5.87e-06	8.65e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—EP300—colon cancer	5.81e-06	8.56e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PPARG—colon cancer	5.57e-06	8.2e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PPARG—colon cancer	5.54e-06	8.15e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.4e-06	7.95e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—AKT1—colon cancer	5.4e-06	7.95e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—EP300—colon cancer	5.34e-06	7.85e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AKT1—colon cancer	5.15e-06	7.58e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PPARG—colon cancer	4.97e-06	7.32e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.93e-06	7.25e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PPARG—colon cancer	4.85e-06	7.14e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PPARG—colon cancer	4.53e-06	6.67e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS2—colon cancer	4.38e-06	6.45e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS2—colon cancer	4.36e-06	6.41e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CA—colon cancer	4.34e-06	6.4e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CA—colon cancer	4.3e-06	6.33e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ABCB1—colon cancer	4.3e-06	6.33e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TYMS—colon cancer	4.22e-06	6.21e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CA—colon cancer	3.95e-06	5.81e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS2—colon cancer	3.91e-06	5.76e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS2—colon cancer	3.82e-06	5.62e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—EP300—colon cancer	3.64e-06	5.37e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—EP300—colon cancer	3.62e-06	5.33e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS2—colon cancer	3.57e-06	5.25e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AKT1—colon cancer	3.55e-06	5.22e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AKT1—colon cancer	3.51e-06	5.17e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—EP300—colon cancer	3.25e-06	4.79e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AKT1—colon cancer	3.22e-06	4.75e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—EP300—colon cancer	3.17e-06	4.67e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PPARG—colon cancer	2.99e-06	4.4e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—EP300—colon cancer	2.97e-06	4.37e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CA—colon cancer	2.7e-06	3.97e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CA—colon cancer	2.68e-06	3.95e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CA—colon cancer	2.41e-06	3.54e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS2—colon cancer	2.35e-06	3.46e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CA—colon cancer	2.35e-06	3.46e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKT1—colon cancer	2.2e-06	3.24e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CA—colon cancer	2.19e-06	3.23e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKT1—colon cancer	2.19e-06	3.22e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKT1—colon cancer	1.97e-06	2.89e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—EP300—colon cancer	1.96e-06	2.88e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKT1—colon cancer	1.92e-06	2.82e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKT1—colon cancer	1.79e-06	2.64e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CA—colon cancer	1.45e-06	2.13e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKT1—colon cancer	1.18e-06	1.74e-05	CbGpPWpGaD
